Publications

Aspyre-Lung enables robust variant calling in samples that fail next generation sequencing quality control

1759eP Fast and simple biomarker testing qPCR platform for simultaneous DNA and RNA variant detection in non-small cell lung cancer clinical trials using tissue or liquid biopsies

Enspyre: a novel enrichment technology for selected DNA variants using pyrophosphorolysis

Development of a machine learning model for Aspyre Lung Blood: a new assay for rapid detection of actionable variants from plasma in NSCLC patients

Aspyre Clinical Test for Lung® (Blood): Validation of a simple, fast, robust and novel method for multi-variant genomic analysis of actionable NSCLC variants in plasma

Enspyre MRD: a novel enrichment approach for ultra-low variant detection with reduced sequencing requirements

Performance evaluation of the Aspyre Clinical Test for Lung (Tissue) at Low Nucleic Acid Input

Enspyre: A novel enrichment technology for selected DNA variants using pyrophosphorolysis

Evaluation of the Aspyre Lung targeted variant panel: a rapid, low-input solution for non-small cell lung cancer biomarker testing and experience from three independent sites

Aspyre Clinical Test for Lung: validation of a simple, fast and robust method for molecular profiling of actionable variants in plasma

Development of a machine learning model for Aspyre Lung (Blood): a new assay for rapid detection of actionable variants from plasma in NSCLC patients

Aspyre® Lung: validation of a simple, fast, robust and novel method for multi-variant genomic analysis of actionable NSCLC variants in FFPE tissue

Aspyre® Lung addresses critical gaps in NGS-based biomarker testing: robust variant calling from NGS QC fails

Deployment of Aspyre® Lung targeted variant panel across three sites and testing with FFPE tissue and cytology-derived nucleic acid samples

Aspyre® Lung: Validation of a simple, fast, robust and novel method for multi-variant genomic analysis of actionable NSCLC variants in FFPE tissue

Validation of a simple, fast and robust novel method for complex genomic analysis of actionable NSCLC variants in tissue and plasma

Ultra-sensitive molecular detection of gene fusions from RNA using Aspyre®

External user testing of Biofidelity’s Aspyre® Lung assay demonstrates breakthrough capabilities and ease of use

Low-cost, simple and rapid assay for single-molecule detection of gene fusions from RNA with Aspyre®

Ultra-sensitive molecular detection of gene fusions from RNA using Aspyre®

Single-copy detection of somatic variants from solid and liquid biopsy